ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE Option for exclusive licence to highly sensitive NGS ...

The agreement for the use of NuProbe’s NGS panel will support the accelerated development of Angle’s pan-cancer assay.

Most patients with advanced prostate cancer or urothelial cancer are not undergoing next-generation sequencing, a new study suggests.

CleanNGS Dx is CleanNA’s third CE-IVD compliant product launched over the course of a year, after the Clean Cell Free DNA Kit ...

The field of plant virology has seen significant advancements with the advent of next-generation sequencing (NGS) ...

Results from a new University of Kentucky Markey Cancer Center study show that molecular tumor boards can play an important ...

ANGLE plc has signed an agreement with NuProbe USA to use its pan-cancer next generation sequencing panel. NuProbe has granted ANGLE ...

Metagenomic sequencing uses next generation sequencing (NGS) to rapidly identify and analyze microbial community diversity and understand the role of constituent species. Our proprietary microbial ...

Integrated DNA Technologies (IDT) has introduced the Archer VARIANTPlex Lymphoma panel, a new tool for next-generation sequencing (NGS) to add to its ...

QIAGEN N.V.QGEN and Becton, Dickinson and Company or BD’s BDX joint venture, PreAnalytiX GmbH, recently launched the PAXgene ...